Julien Hanson
Julien Hanson
F.R.S.-FNRS Principal Investigator, Head of the Laboratory of Molecular Pharmacology, University of
Adresse e-mail validée de - Page d'accueil
Citée par
Citée par
The Concise Guide to PHARMACOLOGY 2019/20: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 176, S21-S141, 2019
The Concise Guide to PHARMACOLOGY 2021/22: G protein‐coupled receptors
SPH Alexander, A Christopoulos, AP Davenport, E Kelly, A Mathie, ...
British journal of pharmacology 178, S27-S156, 2021
An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81
K Ahmed, S Tunaru, C Tang, M Müller, A Gille, A Sassmann, J Hanson, ...
Cell metabolism 11 (4), 311-319, 2010
The concise guide to pharmacology 2017/18: overview
SPH Alexander, E Kelly, NV Marrion, JA Peters, E Faccenda, SD Harding, ...
British journal of pharmacology 174, S1-S16, 2017
Nicotinic acid–and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
J Hanson, A Gille, S Zwykiel, M Lukasova, BE Clausen, K Ahmed, ...
The Journal of clinical investigation 120 (8), 2910-2919, 2010
Coxibs and cardiovascular side-effects: from light to shadow
JM Dogné, J Hanson, C Supuran, D Pratico
Current pharmaceutical design 12 (8), 971-975, 2006
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis
JM Dogné, J Hanson, D Pratico
Trends in pharmacological sciences 26 (12), 639-644, 2005
Insight into SUCNR1 (GPR91) structure and function
J Gilissen, F Jouret, B Pirotte, J Hanson
Pharmacology & therapeutics 159, 56-65, 2016
New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators
JM Dogné, X Leval, J Hanson, M Frederich, B Lambermont, A Ghuysen, ...
Current medicinal chemistry 11 (10), 1223-1241, 2004
New developments on thromboxane and prostacyclin modulators part II: prostacyclin modulators
X Leval, J Hanson, JL David, B Masereel, B Pirotte, JM Dogné
Current medicinal chemistry 11 (10), 1243-1252, 2004
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
M Lukasova, J Hanson, S Tunaru, S Offermanns
Trends in pharmacological sciences 32 (12), 700-707, 2011
The G protein-coupled receptors deorphanization landscape
C Laschet, N Dupuis, J Hanson
Biochemical Pharmacology 153, 62-74, 2018
Deorphanization of GPR109B as a receptor for the β-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis
K Ahmed, S Tunaru, CD Langhans, J Hanson, CW Michalski, S Kölker, ...
Journal of Biological Chemistry 284 (33), 21928-21933, 2009
From the design to the clinical application of thromboxane modulators
JM Dogné, J Hanson, X Leval, D Pratico, CR Pace-Asciak, P Drion, ...
Current pharmaceutical design 12 (8), 903-923, 2006
Formation, signaling and occurrence of specialized pro-resolving lipid mediators—what is the evidence so far?
NH Schebb, H Kühn, AS Kahnt, KM Rund, VB O’Donnell, N Flamand, ...
Frontiers in pharmacology 13, 838782, 2022
The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment
N Reynders, D Abboud, A Baragli, MZ Noman, B Rogister, SP Niclou, ...
Cells 8 (6), 613, 2019
Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin
J Hanson, A Gille, S Offermanns
Pharmacology & therapeutics 136 (1), 1-7, 2012
Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3
M Szpakowska, AM Nevins, M Meyrath, D Rhainds, T D'huys, ...
British journal of pharmacology 175 (9), 1419-1438, 2018
Forskolin-free cAMP assay for Gi-coupled receptors
J Gilissen, P Geubelle, N Dupuis, C Laschet, B Pirotte, J Hanson
Biochemical Pharmacology 98 (3), 381-391, 2015
The causes and consequences of pituitary gigantism
A Beckers, P Petrossians, J Hanson, AF Daly
Nature Reviews Endocrinology 14 (12), 705-720, 2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20